115 related articles for article (PubMed ID: 1383627)
21. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
[TBL] [Abstract][Full Text] [Related]
22. Overview of the effects of intravenous milrinone in acute heart failure following surgery.
Copp MV; Hill AJ; Feneck RO
Eur J Anaesthesiol Suppl; 1992; 5():35-41. PubMed ID: 1600968
[TBL] [Abstract][Full Text] [Related]
23. Repletion of high energy phosphates in the postischemic neonatal heart.
Pridjian AK; VanMeter CH; McFadden PM; Chung KC; Touchard CL; Ochsner JL
Am Surg; 1996 Jun; 62(6):494-8. PubMed ID: 8651536
[TBL] [Abstract][Full Text] [Related]
24. Positive functional effects of milrinone and methylene blue are not additive in control and hypertrophic canine hearts.
Leone RJ; Weiss HR; Scholz PM
J Surg Res; 1998 Jun; 77(1):23-8. PubMed ID: 9698527
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of intravenous milrinone in the treatment of acute congestive cardiac failure. Results of a French multicenter study].
Dubois-Randé JL; Guérot C; Jan F; Brochier M; Sacrez A; Vacheron A; Bory M; Lambert H; Pony JC; Le Bloc'h Y
Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):105-14. PubMed ID: 8494318
[TBL] [Abstract][Full Text] [Related]
26. Myocardial and vascular effects of intracoronary versus intravenous milrinone.
Colucci WS; Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E
Trans Assoc Am Physicians; 1985; 98():136-45. PubMed ID: 3842193
[No Abstract] [Full Text] [Related]
27. Cardiovascular and renal effects of milrinone in beta-adrenoreceptor blocked and non-blocked anaesthetized dogs.
Lee KC; Canniff PC; Hamel DW; Pagani ED; Ezrin AM
Drugs Exp Clin Res; 1991; 17(3):145-58. PubMed ID: 1680619
[TBL] [Abstract][Full Text] [Related]
28. [The effects of milrinone on hemodynamics in patients undergoing cardiac surgery].
Iwagaki T; Irie J; Ijichi K; Uratsuji Y
Masui; 2001 Apr; 50(4):360-4. PubMed ID: 11345746
[TBL] [Abstract][Full Text] [Related]
29. Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction.
Lilleberg J; Sundberg S; Nieminen MS
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S63-9. PubMed ID: 8907133
[TBL] [Abstract][Full Text] [Related]
30. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators.
Seino Y; Momomura S; Takano T; Hayakawa H; Katoh K
Crit Care Med; 1996 Sep; 24(9):1490-7. PubMed ID: 8797620
[TBL] [Abstract][Full Text] [Related]
31. Effects of milrinone on left ventricular cardiac function during cooling in an intact animal model.
Tveita T; Sieck GC
Cryobiology; 2012 Aug; 65(1):27-32. PubMed ID: 22465655
[TBL] [Abstract][Full Text] [Related]
32. Effects of variable dose milrinone in patients with low cardiac output after cardiac surgery. European Multicenter Trial Group.
Feneck RO
Am Heart J; 1991 Jun; 121(6 Pt 2):1995-9. PubMed ID: 2035429
[TBL] [Abstract][Full Text] [Related]
33. Effects of the new phosphodiesterase-III inhibitor R80122 on contractility and calcium current in human cardiac tissue.
Li Q; Himmel HM; Ravens U
J Cardiovasc Pharmacol; 1994 Jul; 24(1):133-43. PubMed ID: 7521478
[TBL] [Abstract][Full Text] [Related]
34. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
[TBL] [Abstract][Full Text] [Related]
35. Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group.
Feneck RO
J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):554-62. PubMed ID: 1421066
[TBL] [Abstract][Full Text] [Related]
36. Clinical and haemodynamic effects of milrinone in the treatment of low cardiac output after cardiac surgery.
Wright EM; Sherry KM
Br J Anaesth; 1991 Nov; 67(5):585-90. PubMed ID: 1751273
[TBL] [Abstract][Full Text] [Related]
37. Comparative cardiac effects of milrinone and sodium nitroprusside in conscious rats.
Desjardins S; Cauchy MJ
Drug Chem Toxicol; 1995 Feb; 18(1):43-59. PubMed ID: 7768199
[TBL] [Abstract][Full Text] [Related]
38. Effects of milrinone and sulmazole on left ventricular mechanoenergetics in canine hearts.
Hata K; Goto Y; Futaki S; Takasago T; Saeki A; Nishioka T; Suga H
J Card Fail; 1996 Sep; 2(3):203-13. PubMed ID: 8891859
[TBL] [Abstract][Full Text] [Related]
39. Does intravenous milrinone have a direct effect on diastolic function?
Krams R; McFalls E; van der Giessen WJ; Serruys PW; Verdoun PD; Roelandt J
Am Heart J; 1991 Jun; 121(6 Pt 2):1951-5. PubMed ID: 2035426
[TBL] [Abstract][Full Text] [Related]
40. Effects of a new cardiotonic phosphodiesterase III inhibitor, olprinone, on cardiohemodynamics and plasma hormones in conscious pigs with heart failure.
Adachi H; Tanaka H
J Cardiovasc Pharmacol; 1997 Jun; 29(6):763-71. PubMed ID: 9234657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
